Dario Trapani, Medical Oncologist at European Institute of Oncology (IEO), Researcher at Department of Oncology and Hemato-Oncology at University of Milan, shared a post on LinkedIn:
“Treatment modulation that is risk-informed and biomarker-oriented is central in modern oncology, to provide the ‘right dose’ and the ‘right size’ to patients with cancer.
Optimizing care requires a triple focus:
- prioritizing outcomes that ‘matter’ for patients
- honoring individual patient priorities
- ensuring feasibility within health system constraints
Driven by best science and methodological rigor.
In a recent conversation at The Netherlands Cancer Institute for the EUnetCCC – European Network of Comprehensive Cancer Centres, we reflected on the current challenges, barriers and potential solutions in an incredible multi-stakeholder panel, driven by patients, inspired by best practices.
Other articles featuring Dario Trapani on OncoDaily.